Our editorial approach is independent, AI-assisted research organized around distinct reader questions. Publication requires checking specific medical claims against identifiable sources available at the time, prioritizing FDA prescribing information, DailyMed, MedlinePlus and relevant clinical guidance. A source name or reference URL is a research starting point, not proof that its contents have been verified. Unavailable sources and unresolved claims must be identified, qualified or omitted. This blueprint does not represent completed live source verification.
Articles must distinguish approved labeling from off-label discussion, compounded formulations and products whose approval status has not been established. Dose comparisons explain labeling and prescribing considerations rather than selecting a dose for the reader. Treatment claims require supporting evidence; discounts, seller popularity, packaging and customer testimonials cannot establish medicine safety or authenticity. Prices, availability and shipping statements require dates and applicable conditions. Authors, reviewers, credentials and review dates may be displayed only when truthful and documented.
Images must have a documented license or other valid permission, with plain-text creator and source credits. Reference pages do not authorize copying their text or images, and images must not be hotlinked. Generated pictures must be captioned as generated conceptual illustrations and cannot serve as photographs of supplied medicine, authenticity comparisons, medical evidence or official packaging. Prefer explanatory diagrams that avoid fabricated brand marks and prescription documents.
Corrections are accepted through the contact form. Substantiated errors should be corrected, and material changes should be explained on the affected article. Keep articles focused, avoid repetitive product-name substitutions, and publish only after the configured editorial and image checks are complete.